secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2026-08-05T10:05:30+00:00
Accession:  0001639691-26-000085
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova Q2 revenue up 10.8% to $390.6M; raises FY2026 guidance
---------------------------------------------------------------

- Q2 GAAP diluted EPS $1.93; adjusted diluted EPS $1.26; revenue $390.6M (+10.8% reported, +9.8% constant currency).
- Raised FY2026 constant-currency revenue growth guidance to 8%-9% (up 100 bps); adjusted EPS guidance raised to $4.30-$4.40 (midpoint +$0.10).
- Lowered FY2026 adjusted free cash flow guidance to $140M-$160M; Q2 adjusted free cash flow $45.5M.
- Recognized €81.8M ($95.4M) discrete tax benefit from favorable Italian tax authority ruling on SNIA environmental liability.
- Entered long-term agreement with Thermo Fisher Scientific to increase oxygenator component supply and expand manufacturing output.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969126000085/0001639691-26-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969126000085/livn-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001639691-26-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer